101 related articles for article (PubMed ID: 33423492)
1. Three-Dimensional, Scaffolded Tumor Model to Study Cell-Driven Microenvironment Effects and Therapeutic Responses.
Ornell KJ; Mistretta KS; Newman E; Ralston CQ; Coburn JM
ACS Biomater Sci Eng; 2019 Dec; 5(12):6742-6754. PubMed ID: 33423492
[TBL] [Abstract][Full Text] [Related]
2. Development of a stacked, porous silk scaffold neuroblastoma model for investigating spatial differences in cell and drug responsiveness.
Ornell KJ; Mistretta KS; Ralston CQ; Coburn JM
Biomater Sci; 2021 Feb; 9(4):1272-1290. PubMed ID: 33336667
[TBL] [Abstract][Full Text] [Related]
3. Development of a mechanically matched silk scaffolded 3D clear cell renal cell carcinoma model.
Abbott A; Bond K; Chiba T; Sims-Lucas S; Oxburgh L; Coburn JM
Mater Sci Eng C Mater Biol Appl; 2021 Jul; 126():112141. PubMed ID: 34082952
[TBL] [Abstract][Full Text] [Related]
4. Activation of a prometastatic gene expression program in hypoxic neuroblastoma cells.
Poomthavorn P; Wong SH; Higgins S; Werther GA; Russo VC
Endocr Relat Cancer; 2009 Sep; 16(3):991-1004. PubMed ID: 19423615
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional porous silk tumor constructs in the approximation of in vivo osteosarcoma physiology.
Tan PH; Aung KZ; Toh SL; Goh JC; Nathan SS
Biomaterials; 2011 Sep; 32(26):6131-7. PubMed ID: 21621837
[TBL] [Abstract][Full Text] [Related]
6. A physiologically relevant 3D collagen-based scaffold-neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models.
Curtin C; Nolan JC; Conlon R; Deneweth L; Gallagher C; Tan YJ; Cavanagh BL; Asraf AZ; Harvey H; Miller-Delaney S; Shohet J; Bray I; O'Brien FJ; Stallings RL; Piskareva O
Acta Biomater; 2018 Apr; 70():84-97. PubMed ID: 29447961
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
Yang B; Keshelava N; Anderson CP; Reynolds CP
Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899
[TBL] [Abstract][Full Text] [Related]
8. 3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways.
DelNero P; Lane M; Verbridge SS; Kwee B; Kermani P; Hempstead B; Stroock A; Fischbach C
Biomaterials; 2015 Jul; 55():110-8. PubMed ID: 25934456
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
10. Artificial neural network classifier predicts neuroblastoma patients' outcome.
Cangelosi D; Pelassa S; Morini M; Conte M; Bosco MC; Eva A; Sementa AR; Varesio L
BMC Bioinformatics; 2016 Nov; 17(Suppl 12):347. PubMed ID: 28185577
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional culture of mouse bone marrow cells within a porous polymer scaffold: effects of oxygen concentration and stromal layer on expansion of haematopoietic progenitor cells.
Miyoshi H; Murao M; Ohshima N; Tun T
J Tissue Eng Regen Med; 2011 Feb; 5(2):112-8. PubMed ID: 20653040
[TBL] [Abstract][Full Text] [Related]
12. Neuroblastoma survival and death: an in vitro model of hypoxia and metabolic stress.
Prabhakaran K; Sampson DA; Hoehner JC
J Surg Res; 2004 Feb; 116(2):288-96. PubMed ID: 15013368
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site.
Rössler J; Stolze I; Frede S; Freitag P; Schweigerer L; Havers W; Fandrey J
J Cell Biochem; 2004 Sep; 93(1):153-61. PubMed ID: 15352172
[TBL] [Abstract][Full Text] [Related]
14. Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies.
Marrella A; Dondero A; Aiello M; Casu B; Olive D; Regis S; Bottino C; Pende D; Meazza R; Caluori G; Castriconi R; Scaglione S
Front Immunol; 2019; 10():1876. PubMed ID: 31447858
[TBL] [Abstract][Full Text] [Related]
15. Combined targeted therapy with PI3K and CDK4/6, or FGFR inhibitors show synergistic effects in a neuroblastoma spheroid culture model.
Lukoseviciute M; Need E; Holzhauser S; Dalianis T; Kostopoulou ON
Biomed Pharmacother; 2024 Jun; 177():116993. PubMed ID: 38889643
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of PDK1, PHD3 and HIF-1α expression defines the hypoxic status of neuroblastoma tumors.
Ognibene M; Cangelosi D; Morini M; Segalerba D; Bosco MC; Sementa AR; Eva A; Varesio L
PLoS One; 2017; 12(11):e0187206. PubMed ID: 29117193
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
[TBL] [Abstract][Full Text] [Related]
18. Induced differentiation affords neuroblastoma cells protection from hypoxic injury.
Hoehner JC; Prabhakaran K
J Pediatr Surg; 2003 Jul; 38(7):1069-74. PubMed ID: 12861542
[TBL] [Abstract][Full Text] [Related]
19. Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line.
Liu L; Li Y; Xiong X; Qi K; Zhang C; Fang J; Guo H
Int J Oncol; 2016 Dec; 49(6):2319-2330. PubMed ID: 27840903
[TBL] [Abstract][Full Text] [Related]
20. A Novel 3D in Vitro Tumor Model Based on Silk Fibroin/Chitosan Scaffolds To Mimic the Tumor Microenvironment.
Li J; Zhou Y; Chen W; Yuan Z; You B; Liu Y; Yang S; Li F; Qu C; Zhang X
ACS Appl Mater Interfaces; 2018 Oct; 10(43):36641-36651. PubMed ID: 30360129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
